chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fatigue; nausea; mouth numbness; sore throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Apr2021 15:15 (Lot number: EP7533) at the age of 43 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: LYSINE; SAW PALMETTO [SERENOA REPENS]; FISH OIL. Vaccination history included: Bnt162b2 (Dose number: 1, Lot number: EN6204, Administration date: 09Mar2021, Administration time: 03:30 PM, Vaccine location= Left arm), administration date: 09Mar2021, when the patient was 43 years old, for Covid-19 immunisation, reaction(s): "arm pain for 3-4 weeks at injection site". The following information was reported: FATIGUE (non-serious) with onset Apr2021, outcome "unknown", described as "fatigue"; NAUSEA (non-serious) with onset Apr2021, outcome "unknown", described as "nausea"; HYPOAESTHESIA ORAL (non-serious) with onset Apr2021, outcome "unknown", described as "mouth numbness"; OROPHARYNGEAL PAIN (non-serious) with onset Apr2021, outcome "unknown", described as "sore throat". Therapeutic measures were not taken as a result of fatigue, nausea, hypoaesthesia oral, oropharyngeal pain.  Additional information: Patient had no allergies. Patient received multi-vitamin as concomitant medication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination.   No follow-up attempts are possible. No further information is expected.
Patient discharged after (11) day inpatient admission. H & P: Patient is a 70 y.o. male who presents today with intense fatigue, malaise, anorexia for the past few weeks. He tested positive for Covid 11 days ago, finally comes in because he cannot care for himself, can barely walk. He has PMH of chronic back pain, never smoker, he is vaccinated. In the ED, he is normoxic on RA, vital stable, but very weak. He has some chest pain that sounds like costochondritis, he is given Toradol. CXR shows bilateral infiltrates. He requires admission for Covid infection with bilateral pneumonia.  Assessment & Plan -He says he's had s/s for a few weeks -Normoxic on RA, but very fatigued -Tested (+) on 11/22, so unfortunately not eligible for MAB's -Dimer 640, ferritin 937  -Has been eating/drinking very little for the past week at least -However is hungry now; appears dry, give 500mL NS to total 1500 fluids IV -Give Lovenox/dexamethasone BID, vit's, mucinex   Bilateral pulmonary infiltrates on CXR Assessment & Plan -Consistent with Covid pneumonia -However with prolonged course, age will cover for CAP   Hyponatremia Assessment & Plan -Mild at 133, expect to improve with diet/cautious fluids   Elevated C-reactive protein (CRP) Assessment & Plan -Secondary to Covid, likely
Fever, nausea, sore arm, increased fatigue, warmth to injection site; swelling    Missed 1 full day of work and left early on one day
Left arm weakness for a week; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 49-year-old male patient received BNT162b2 (BNT162B2), on 08Oct2021 as dose 3 (booster), single (Lot number: FF2588) at the age of 48 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: EK570), administration date: 17Dec2020, when the patient was 47-year-old, for Covid-19 Immunization; BNT162b2 (DOSE 2, SINGLE; Lot number: EL3246), administration date: 06Jan2021, when the patient was 48-year-old, for Covid-19 Immunization. The following information was reported: MUSCULAR WEAKNESS (non-serious), outcome "unknown", described as "Left arm weakness for a week". Therapeutic measures were not taken as a result of muscular weakness.  Follow-up attempts are completed. No further information is expected.
On Monday I started vomitting and couldn't keep anything down for 12 hrs. I had to take medication to stop the vomitting.
About 7 hours after the shot (around 9pm) nausea began. Then violent shaking chills. Then a severe migraine. There was NO fever. Was unable to sleep. This kept me up all night. By the early morning, the chills and nausea had subsided, but the migraine continued for several more hours.
Vomited x 1 12 hours post vaccination and vomited x 1 22 hours post vaccination
Information has been received from a health professional from the local county health department concerning a 43 year old Hispanic female who was vaccinated subcutaneously with 0.5 ml of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). On approximately 28 MAY 2007, "last week", the patient "developed a rash on her torso from her neck down to her legs after receiving a measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) injection". Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
(R) thigh with bruising. 1 x 2 cm knots felt in muscle. No exudate. Non tender.
In January, I went to my primary care physician for my normal physical and when they took my BP it was elevated 142/ 89, and I was on medication, and they asked me to come back 3 weeks later, and it was elevated even more 158/92. They added in medication. They place me on a diuretic. March 8th, I had a blood test, and my creatine/ bun was extremely high, and they stopped the diuretic. They switched out my medicine and that has leveled out except now my calcium score is high and I'm going to see an endocrinologist and they believe something with my parathyroid is off.
General Symptoms: Chills, Fever, headaches, fatigue, nausea, vomiting] Narrative:
fever last night (temperature was not taken); the Patient being hot and cold throughout the night; pain at the injection site only when the injection site is pressed; localized redness at the injection site; localized fluid filled blister only at the injection site; This is a spontaneous report from a contactable consumer (Daughter reported for patient). A 79-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 23Feb2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the consumer reported that the patient had a fever last night (temperature was not taken) as the patient reports being hot and cold throughout the night, having pain at the injection site only when the injection site is pressed, localized redness at the injection site and a localized fluid filled blister only at the injection site. The consumer requesting to know if the blistering had been reported as a side effect from the Pfizer COVID-19 vaccine. The patient underwent lab tests and procedures which included body temperature: unknown an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Red Rash on lower Right and Left forearm / Top of both feet /  Back of thigh around the knee.
DILUENT FOR PFIZER VACCINE - 0.9% sodium CHLORIDE iNJECTION - 0.3 ML WAS ACCIDENTLY GIVEN TO PT.
This spontaneous report has been received from a 78 year old female patient concerning herself without any drug reactions/allergies. The patient's medical history included asthma. On 16-OCT-2012 the patient was vaccinated with a sing injection of 0.65 ml ZOSTAVAX (lot number unspecified) subcutaneous at a local pharmacy. There was no concomitant medications. The patient stated she had broken out in a rash on her back that looked like "prickly heat". The rash began forming on 31-AUG-2013. The patient said she felt jabbing pains in the area of her back where the rash was. The outcome of the events was not recovered/not resolved. The patient had not yet contacted her doctor but planned to do so. Additional information has been requested.
Sudden fast heart/pounding  rate about 30 min after vaccination. Followed by immediate warm feeling, light headedness (similar to feeling of passing out).  Every 10-15 min after that for the next 90 minutes a similar but less intense increase in heart rate would occur.  During this next 90 minutes my hands were very tingly and clammy, my adrenaline seemed high, and my throat was suddenly very dry requiring several cups of water.  Overall intensity of the heart pounding sensation decreased with each episode and overall my heart felt normal about 2 hrs past vaccination.  A headache then developed along with fogginess and persisted the rest of the day.
p/recv vax pt exp inj site react consisted of swelling & discomfort at site;
received 2nd dose at 7pm 1/18/21. woke up tuesday with sore arm went to work and while working afternoon  progressed to chills and total body aches.   temp 101 through evening  up and down  after motrin to next day Wednesday. wednesday had some chills but during night into Thursday  had joint pain no fever.   woken up thursday with joint pain and headache no fever.
fever, body ache, nausea, lightheadedness, sneezing, stuffy nose
Adverse Events:  I went to the emergency room on 5/18 after experiencing major back pain, sharp pain in ribs, chest pains, difficulty breathing, shortness of breath and chronic coughing.   Outcome:  After x-rays, EKG, D-Dimer Test and a CT scan the doctor determined that I have Pulmonary Embolism (blood clots in my lungs).   I've never had any symptoms prior to receiving the covid vaccine. Today is 5/24 and I am still experiencing most of the same symptoms despite taking my medications as prescribed. The worst symptoms are difficulty breathing and chronic coughing.   Treatment:  -No longer taking birth control (Azurette) since that can cause blood cots -Xarelto (to treat and prevent blood clots)  -Gabapentin 100MG 3x Day (for pain) -Benzonatate 200MG 3x Day (for cough) -Tizanidine 2MG 1X day (for pain) -Albuterol Inhaler Every 4 hours
Cough after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough after vaccination) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced COUGH (Cough after vaccination). At the time of the report, COUGH (Cough after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Expired Engerix administered; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received HBV (Engerix B) (batch number N4GA4, expiry date 2nd January 2023) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 7th February 2023, the patient received Engerix B and Engerix B Pre-Filled Syringe Device. On 7th February 2023, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 07-FEB-2023 Reporter's Comment: The pharmacist reported that a nurse inadvertently administered an expired dose of Engerix-B. The additional patient information was not known. The reporter consent to follow up via email. Additional Supportive Information: The patient received an expired dose of Engerix B, which led to expired vaccine used.
Pt is having pain, decreased ROM, and nerve damage. 1.5 inch needle used - staff were out of 1 inch.  She has been seen by 3 MD's.
First dose: gas; sore arm; This is a spontaneous report received from a contactable Nurse (patient). This 70-year-old (same age at vaccination) female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, lot: EM9809) via an unspecified route of administration on 22Feb2021 at 11:30 AM in left arm as single dose to prevent Covid 19 virus. Medical history reported was parkinsons disease, chronic lymphocytic leukemia, sleep apnea, chronic fatigue, hypothyroidism, all ongoing. She has not had any changes to her medications. She has taken the same medications for years. Concomitant medication reported was immunoglobulin g human (IGG) ongoing Infusion, every 4 weeks. Patient does have a slight allergy to Miralax. She vomited when she took it. She had the Miralax in 2012 when she broke her hip, she was at a rehab hospital. The hospital didn't have any prunes, so they gave her Miralax twice. She reported she has no immunity because of her cancer, and she was hoping she can still receive the Covid 19 vaccine booster if needed. She received her IgG infusion on the days after she received her first and second Covid 19 vaccine. She's been getting IgG for 15 years. The patient experienced gas after first dose of vaccine on an unspecified date.it was reported She did fine with the first Covid 19 vaccine other than some gas. She reported she was a very young and very active. She mentioned to have maybe a sore arm on an unspecified date. The patient underwent investigations on an unspecified date included, blood work, Electromyographic Nerve Test with unspecified result and units and COVID-19 antibody test with negative result. Outcome of the events was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
The patient's parent stated the patient broke out in a rash all over his body except his face. The patient was very fussy. The patient was not treated as the rash cleared up on it's own.
CLIENT STATES THAT AT THE TIME OF VACCINATION HE FELT SOME OF THE VACCINE DRIP DOWN HIS ARM. HE IS REPORTING BECAUSE HE WANTS TO BE SURE HE WAS GIVEN ENOUGH VACCINE AND IT DOESNT NEED REPEATED. HE STATED HE ASKED THE PERSO ADMINISTERING AND THEY SAID THAT IT WAS FINE AND THAT SOMETIMES SOME LEAKS OUT.
pt was fine for 2 1/2 hrs p/shot then screamed for 6 1/2 hrs call MD who ordered APAP; pt slept but was awake during noc w/short episodes of crying; no redness or swelling @ inject site;
Information has been received from a physician concerning a 7 year old female with no pertinent medical history or drug allergies who on 11-JUL-2007 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck) (Lot# 0592U). There was no concomitant medication. On 12-JUL-2007 the patient developed injection site redness and injection site swelling 3 inches in diameter size. Office was contacted on 12-JUL-2007 and 13-JUL-2007. No labs were performed. The patient's present status was unknown. No product quality complaint reported. Additional information has been requested.
Izs all given too early by mistake, no adverse reactions seen. Follow-up Information 12-SEP-2007: No adverse event. Patient did well. Vaccine just given at 4 wks of age by mistake.
p/vax pt exp redness & swelling along anterior portion of lt upper arm; soreness; sl warmth
Per Client on 1/27/2021 at 6:00 am awaken to left under eye lid swollen and tender. Per Client no medication taken for symptoms. Currently have not been seen by medical provided regarding symptoms. Per Client symptoms have not resolved and is planning to follow up with PCP today.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 29-JUL-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5ml, lot # K005957, expiration date 08-MAR-2015, route unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 1152 hours with lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
the patient was administered an improperly stored dose of Rotateq; This spontaneous report was received from a nurse and refers to patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 19-MAY-2020, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) ( lot # S013890, expiry date: 14-FEB-2021; dose, dose number, route of administration were not provided) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 12.1 degrees Celsius for 16 hours and 11 minutes. There were no previous excursions related. Data logger was involved.
I received my second covid 19 vaccine on 1/18/21.  I was 7 weeks pregnant at that time.  About 14 hours after receiving the injection, I developed a fever of 100.4 accompanied by feeling unwell like I had the flu.  Symptoms included local pain at the injection site, chills, malaise, headache, joint pains and fever with temp max of 102.6 at about 26 hours post vaccine.  Tylenol 1000mg taken.  Then I slept until the next morning.  Symptoms improved by 36 hours post vaccine.  Afebrile but feeling tired following throughout the next day.
This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients of unknown demographics. In 2014 (exact date unspecified), those patients were vaccinated with an improperly stored for 8 days from 24-OCT-2014 through 31-OCT-2014 GARDASIL (dose, route of administration, anatomical location, lot number were not reported). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Hospitalized (3.21.22-3.31.22);  COVID-19 positive (3.3.22 and 3.24.22); fully vaccinated PLUS booster  BRIEF OVERVIEW: Primary Care Physician at Discharge:  Hematologist/Oncologist:  Admission Date: 3/21/2022 Discharge Date: 03/31/2022 Patient's Discharge Disposition:  Home in stable condition. Discharge summary: This is a 76 y.o. year old patient who was admitted on 3/21/2022 with PMH of PE, HLD, HTN, asthma, anemia, and lymphoma. Patient presented to the ED for SOB and cough x 3 weeks. Patient stated she tested positive for COVID on 3/2 and had since had worsening SOB with exertion and cough. Again positive for COVID on 3/21. CTA of chest with groundglass opacities consistent with airspace disease and tiny PE. No evidence of right heart strain. 3/22 echo with 65% LVEF and normal RV function. Pt started on rocephin and azithromycin, which was completed on 3/30. Pt also received remdesivir and steroids, which completed 3/28. Pt on xarelto at home, which was switched to lovenox. However, pt unable to afford lovenox as outpt, therefore she was discharged on eliquis. Admission complicated by diarrhea and electrolyte abnormalities. Pt negative for c diff and eletrolytes replaced. Pt also with chronic dysphagia, SLP and GI followed during inpt stay. Pt had EGD with dilation on 3/28. With pt's PCM and weakness, PT/OT consulted for assistance with discharge planning. Therapy ultimately recommended HHC PT OT and DME 4WW. Prior to discharge today, patient denies new, worsening or changes in ROS at this time, including no fevers/chills/sweats, no CP/SOB/DOE, no abd pain/N/V/D, and no neuro changes.  Patient eating/drinking/voiding well and ambulating as tolerated.  Patient will plan to follow up in our office with Dr.. Patient's discharge medication plan were discussed as per below and new prescriptions were sent to patient's requested pharmacy prior to discharge as per generated list below.  Patient is aware to call our office should further questions or concerns arise following this discharge.
Itching everywhere, severe swelling and redness at injection site, throat swelling. Symptoms began 15-30 minutes following injection. At 30 minutes, patient took a Diphenhydramine 25mg capsule at home, and symptoms immediately began to subside within another 30 minutes. Patient reported this event on 11/14/19 following a reminder call from our pharmacy for the second dose of Shingrix. Patient refused due to allergic reaction discussed in this report.
Red spot about 1 inch in diameter with swelling and warm to the touch.  Muscle soreness around injection site. Still present two day later with no relief as of reporting.
Developed redness 5 days after vaccine and now with blisters in a cirlce around the injection site after a cold compress 2 days ago.  Warm and swollen.  Came to  Clinic for evaluation and treated with keflex antibiotic for 10 days starting today.
Patient was coming in for second covid vaccine. First vaccine was Pfizer on 12/20/2021 and MA administered Moderna for second dose.
Feeling unwell; Injection site swelling; Joint pain; Nausea; Swollen lymph nodes; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 13:45 (at the age of 75-years-old), as a single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient did not have any allergies to medications, food or other products. The patient had blood type o-negative. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included vitamin B-complex (MANUFACTURER UNKNOWN), vitamin C (MANUFACTURER UNKNOWN), vitamin E (MANUFACTURER UNKNOWN), beta carotene (MANUFACTURER UNKNOWN), St. John's wort (MANUFACTURER UNKNOWN), CLARITIN-D for unknown indications, FLOMAX for benign prostatic hyperplasia and unspecified medication for high blood pressure, all from unknown dates. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12Mar2021 at 13:45, the patient experienced injection site swelling, nausea wave on inject date, swollen lymph nodes, joint pain, tiredness and was feeling unwell through most of the day. The patient had no temperature issues and had not received any flu injection for past 15 to 20 years. The patient did not receive any treatment for the adverse events. The clinical outcome of the events injection site swelling, nausea, swollen lymph nodes, joint pain, tiredness and feeling unwell was recovering.   No follow-up attempts are needed. No further information is expected.
Right arm became very sore 2 hours after vaccination.  But no rash or swelling. Soreness gradually got better over 4 days, but soreness returned 1 week after vaccination and has persisted to current time which is almost 3 weeks since receiving shot.  Interferes with sleep. Tylenol helps.  Still no swelling or rash.
Patient noted symptoms less than 24 hours after receiving injection: fever to 102, shortness ofbreath, and injection site pain.